7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid

C135H147BBr4F3N9O18S7 — CID 162040705

IUPAC7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid
SMILESC=Cc1c(C)cc2nc(C3CC3)sc2c1Br.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(Br)c1O.Cc1cc2nc(C3CC3)sc2c(Br)c1OS(=O)(=O)C(F)(F)F.Cc1cc2nc(C3CC3)sc2c(Br)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.OB(O)c1ccc2c3c(ccnc13)CCO2
InChIInChI=1S/2C33H38N2O4S.C22H30BrNO3S.C13H12BrNS.C12H9BrF3NO3S2.C11H10BNO3.C11H10BrNOS/c2*1-18-16-22-29(40-30(35-22)20-8-9-20)27(21-10-11-23-26-19(13-15-37-23)12-14-34-28(21)26)25(18)24(39-33(5,6)7)17-38-31(36)32(2,3)4;1-12-10-14-18(28-19(24-14)13-8-9-13)17(23)16(12)15(27-22(5,6)7)11-26-20(25)21(2,3)4;1-3-9-7(2)6-10-12(11(9)14)16-13(15-10)8-4-5-8;1-5-4-7-10(21-11(17-7)6-2-3-6)8(13)9(5)20-22(18,19)12(14,15)16;14-12(15)8-1-2-9-10-7(4-6-16-9)3-5-13-11(8)10;1-5-4-7-10(8(12)9(5)14)15-11(13-7)6-2-3-6/h2*10-12,14,16,20,24H,8-9,13,15,17H2,1-7H3;10,13,15H,8-9,11H2,1-7H3;3,6,8H,1,4-5H2,2H3;4,6H,2-3H2,1H3;1-3,5,14-15H,4,6H2;4,6,14H,2-3H2,1H3/t2*24-;15-;;;;/m111..../s1
InChIKeyYXFWCRVYOVMTLN-DSXUXWKVSA-N
MW2795.60 g/mol
LogP36.01
Rot. Bonds24

About 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid

7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid (PubChem CID 162040705) has the molecular formula C135H147BBr4F3N9O18S7 and a molecular weight of 2795.60 g/mol. Its IUPAC name is 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid.

Molecular Properties

Compound Name7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid
PubChem CID162040705
Molecular FormulaC135H147BBr4F3N9O18S7
Molecular Weight2795.60 g/mol
Exact Mass2789.57
IUPAC Name7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid
SMILESC=Cc1c(C)cc2nc(C3CC3)sc2c1Br.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(Br)c1O.Cc1cc2nc(C3CC3)sc2c(Br)c1OS(=O)(=O)C(F)(F)F.Cc1cc2nc(C3CC3)sc2c(Br)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.OB(O)c1ccc2c3c(ccnc13)CCO2
InChIInChI=1S/2C33H38N2O4S.C22H30BrNO3S.C13H12BrNS.C12H9BrF3NO3S2.C11H10BNO3.C11H10BrNOS/c2*1-18-16-22-29(40-30(35-22)20-8-9-20)27(21-10-11-23-26-19(13-15-37-23)12-14-34-28(21)26)25(18)24(39-33(5,6)7)17-38-31(36)32(2,3)4;1-12-10-14-18(28-19(24-14)13-8-9-13)17(23)16(12)15(27-22(5,6)7)11-26-20(25)21(2,3)4;1-3-9-7(2)6-10-12(11(9)14)16-13(15-10)8-4-5-8;1-5-4-7-10(21-11(17-7)6-2-3-6)8(13)9(5)20-22(18,19)12(14,15)16;14-12(15)8-1-2-9-10-7(4-6-16-9)3-5-13-11(8)10;1-5-4-7-10(8(12)9(5)14)15-11(13-7)6-2-3-6/h2*10-12,14,16,20,24H,8-9,13,15,17H2,1-7H3;10,13,15H,8-9,11H2,1-7H3;3,6,8H,1,4-5H2,2H3;4,6H,2-3H2,1H3;1-3,5,14-15H,4,6H2;4,6,14H,2-3H2,1H3/t2*24-;15-;;;;/m111..../s1
InChIKeyYXFWCRVYOVMTLN-DSXUXWKVSA-N
XLogP36.01
TPSA354.35 Ų
H-Bond Donors3
H-Bond Acceptors33
Rotatable Bonds24
Heavy Atoms177
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002795.60
LogP ≤ 536.01
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'}

Analyze 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid?
The IUPAC name of 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid (CID 162040705) is 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid.
What is the SMILES notation for 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid?
The canonical SMILES for 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid is C=Cc1c(C)cc2nc(C3CC3)sc2c1Br.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.Cc1cc2nc(C3CC3)sc2c(Br)c1O.Cc1cc2nc(C3CC3)sc2c(Br)c1OS(=O)(=O)C(F)(F)F.Cc1cc2nc(C3CC3)sc2c(Br)c1[C@@H](COC(=O)C(C)(C)C)OC(C)(C)C.OB(O)c1ccc2c3c(ccnc13)CCO2.
What is the InChIKey of 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid?
The InChIKey is YXFWCRVYOVMTLN-DSXUXWKVSA-N. The full InChI is InChI=1S/2C33H38N2O4S.C22H30BrNO3S.C13H12BrNS.C12H9BrF3NO3S2.C11H10BNO3.C11H10BrNOS/c2*1-18-16-22-29(40-30(35-22)20-8-9-20)27(21-10-11-23-26-19(13-15-37-23)12-14-34-28(21)26)25(18)24(39-33(5,6)7)17-38-31(36)32(2,3)4;1-12-10-14-18(28-19(24-14)13-8-9-13)17(23)16(12)15(27-22(5,6)7)11-26-20(25)21(2,3)4;1-3-9-7(2)6-10-12(11(9)14)16-13(15-10)8-4-5-8;1-5-4-7-10(21-11(17-7)6-2-3-6)8(13)9(5)20-22(18,19)12(14,15)16;14-12(15)8-1-2-9-10-7(4-6-16-9)3-5-13-11(8)10;1-5-4-7-10(8(12)9(5)14)15-11(13-7)6-2-3-6/h2*10-12,14,16,20,24H,8-9,13,15,17H2,1-7H3;10,13,15H,8-9,11H2,1-7H3;3,6,8H,1,4-5H2,2H3;4,6H,2-3H2,1H3;1-3,5,14-15H,4,6H2;4,6,14H,2-3H2,1H3/t2*24-;15-;;;;/m111..../s1.
What are the key properties of 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid?
7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid has a molecular weight of 2795.60 g/mol, XLogP of 36.01, 24 rotatable bonds, 3 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 7-bromo-2-cyclopropyl-6-ethenyl-5-methyl-1,3-benzothiazole;7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-ol;[(2S)-2-(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl)-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate;(7-bromo-2-cyclopropyl-5-methyl-1,3-benzothiazol-6-yl) trifluoromethanesulfonate;bis([(2S)-2-[2-cyclopropyl-5-methyl-7-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]ethyl] 2,2-dimethylpropanoate);2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-ylboronic acid is sourced from PubChem (CID 162040705), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).